Association study of 71 European Crohn's disease susceptibility loci in a Japanese population

Inflammatory Bowel Diseases

Volumn 19, Issue 3, 2013, Pages 526-533

  Hirano, Atsushi ^a,b   Yamazaki, Keiko ^a   Umeno, Junji ^a,b   Ashikawa, Kyota ^a   Aoki, Masayuki ^a   Matsumoto, Takayuki ^b   Nakamura, Shotaro ^b   Ninomiya, Toshiharu ^b   Matsui, Toshiyuki ^c   Hirai, Fumihito ^c   Kawaguchi, Takaaki ^d   Takazoe, Masakazu ^d   Tanaka, Hiroki ^e   Motoya, Satoshi ^e   Kiyohara, Yutaka ^b   Kitazono, Takanari ^b   Nakamura, Yusuke ^f   Kamatani, Naoyuki ^a   Kubo, Michiaki ^a  

^a RIKEN YOKOHAMA INSTITUTE   (Japan)

^b KYUSHU UNIVERSITY   (Japan)

^c Fukuoka University Chikushi Hospital   (Japan)

^d Social Insurance Chuo General Hospital   (Japan)

^e Sapporo Kosei General Hospital   (Japan)

^f UNIVERSITY OF TOKYO   (Japan)

Author keywords

Crohn's disease; Innate immune system; Japanese; TNFSF15

Indexed keywords

ATG16L1 PROTEIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; CCR6 PROTEIN; CD19 ANTIGEN; CD244 ANTIGEN; CD30 LIGAND; CELLUBREVIN; GALC PROTEIN; GCKR PROTEIN; GPR65 PROTEIN; HLA DQ A2 ANTIGEN; HLA DQ ANTIGEN; ICOSLG PROTEIN; INTERLEUKIN 12P40; INTERLEUKIN 27; IRGM PROTEIN; LST1 PROTEIN; LTA PROTEIN; LTB PROTEIN; MLX PROTEIN; PEROXIREDOXIN 5; PLCL1 PROTEIN; PROTEIN; STAT3 PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NKX2.3; TUMOR NECROSIS FACTOR; UBE2D1 PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; YDJC PROTEIN;

ADULT; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; FEMALE; GENE LOCUS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE PHENOTYPE CORRELATION; HUMAN; JAPANESE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; POPULATION GENETICS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; CROHN DISEASE; EUROPE; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNITY, INNATE; JAPAN; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 15;

EID: 84876373775     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1097/MIB.0b013e31828075e7     Document Type: Article

References (38)

1. Franke A, McGovern DP, Barrett JC, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet. 2010;42:1118-1125.
2. Duerr RH, Taylor KD, Brant SR, et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science. 2006; 314:1461-1463.
3. Hampe J, Franke A, Rosenstiel P, et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet. 2007;39:207-211.
4. The Wellcome Trust Case Control Consortium. Association scan of 14, 500 nonsynonymous SNPs in four diseases identifies autoimmunity variants. Nat Genet. 2007;39:1329-1337.
5. Barrett JC, Hansoul S, Nicolae DL, et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease. Nat Genet. 2008;40:955-962.
6. Yamazaki K, McGovern D, Ragoussis J, et al. Single nucleotide polymorphisms in TNFSF15 confer susceptibility to Crohn's disease. Hum Mol Genet. 2005;14:3499-3506.
7. Yamazaki K, Takazoe M, Tanaka T, et al. Absence of mutation in the NOD2/CARD15 gene among 483 Japanese patients with Crohn's disease. J Hum Genet. 2002;47:469-472.
8. Inoue N, Tamura K, Kinouchi Y, et al. Lack of common NOD2 variants in Japanese patients with Crohn's disease. Gastroenterology. 2002;123:86-91.
9. Yamazaki K, Onouchi Y, Takazoe M, et al. Association analysis of genetic variants in IL23R, ATG16L1 and 5p13.1 loci with Crohn's disease in Japanese patients. J Hum Genet. 2007;52:575-583.
10. Yamazaki K, Takazoe M, Tanaka T, et al. Association analysis of SLC22A4, SLC22A5 and DLG5 in Japanese patients with Crohn disease. J Hum Genet. 2004;49:664-668.
11. Prescott NJ, Dominy KM, Kubo M, et al. Independent and populationspecific association of risk variants at the IRGM locus with Crohn's disease. Hum Mol Genet. 2010;19:1828-1839.
12. Yamazaki K, Takahashi A, Takazoe M, et al. Positive association of genetic variants in the upstream region of NKX2-3 with Crohn's disease in Japanese patients. Gut. 2009;58:228-232.
13. Thia KT, Loftus EV, Sandborn WJ, et al. An update on the epidemiology of inflammatory bowel disease in Asia. Am J Gatroenterol. 2008;103: 3167-3182.
14. Ahmad T, Armuzzi A, Bunce M, et al. The molecular classification of the clinical manifestations of Crohn's disease. Gastroenterology. 2002;122: 854-866.
15. Gearry RB, Roberts RL, Burt MJ, et al. Effect of inflammatory bowel disease classification changes on NOD2 genotype-phenotype associations in a population-based cohort. Inflamm Bowel Dis. 2007;13:1220-1227.
16. Economou M, Trikalinos TA, Loizou KT, et al. Differential effects of NOD2 variants on Crohn's disease risk and phenotype in diverse populations: a metaanalysis. Am J Gastroenterol. 2004;99:2393-2404.
17. Adler J, Rangwalla SC, Dwamena BA, et al. The prognostic power of the NOD2 genotype for complicated Crohn's disease: a meta-analysis. Am J Gastroenterol. 2011;106:699-712.
18. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl. 1989;170:2-6.
19. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005;19(suppl A):5-36.
20. Kubo M, Hata J, Ninomiya T, et al. A nonsynonymous SNP in PRKCH (protein kinase C eta) increases the risk of cerebral infarction. Nat Genet. 2007;39:212-217.
21. Nakamura Y. The Biobank Japan Project. Clin Adv Hematol Oncol. 2007; 5:696-7.
22. Ohnishi Y, Tanaka T, Ozaki K, et al. A high-throughput SNP typing system for genome-wide association studies. J Hum Genet. 2001;46: 471-477.
23. Sasieni PD. From genotypes to genes: doubling the sample size. Biometrics. 1997;53:1253-1261.
24. Purcell S, Cherny SS, Sham PC. Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits. Bioinformatics. 2003;19:149-150.
25. Barrett JC, Fry B, Maller J, et al. Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics. 2005;21:263-265.
26. Kakuta Y, Ueki N, Kinouchi Y, et al. TNFSF15 transcripts from risk haplotype for Crohn's disease are overexpressed in stimulated T cells. Hum Mol Genet. 2009;18:1089-1098.
27. John G, Hegarty JP, Yu W, et al. NKX2-3 variant rs11190140 is associated with IBD and alters binding of NFAT. Mol Genet Metab. 2011;104: 174-179.
28. Kuballa P, Huett A, Rioux JD, et al. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLoS One. 2008;3:e3391.
29. McCarroll SA, Huett A, Kuballa P, et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat Genet. 2008;40:1107-1112.
30. Brest P, Lapaquette P, Souidi M, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet. 2011;43:242-245.
31. Scharl M, Mwinyi J, Fischbeck A, et al. Crohn's disease-associated polymorphism within the PTPN2 gene affects muramyl-dipeptideinduced cytokine secretion and autophagy. Inflamm Bowel Dis. 2012; 18:900-912.
32. Gorlatova N, Chao K, Pal LR, et al. Protein characterization of a candidate mechanism SNP for Crohn's disease: the macrophage stimulating protein R689C substitution. PLoS One. 2011;6:e27269.
33. Willing B, Halfvarson J, Dicksved J, et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis. 2009;15:653-660.
34. Travassos LH, Carneiro LA, Ramjeet M, et al. Nod1 and Nod2 direct autophagy by recruiting ATG16L1 to the plasma membrane at the site of bacterial entry. Nat Immunol. 2010;11:55-62.
35. Cooney R, Baker J, Brain O, et al. NOD2 stimulation induces autophagy in dendritic cells influencing bacterial handling and antigen presentation. Nat Med. 2010;16:90-97.
36. Tremelling M, Berzuini C, Massey D, et al. Contribution of TNFSF15 gene variants to Crohn's disease susceptibility confirmed in UK population. Inflamm Bowel Dis. 2008;14:733-737.
37. Thiébaut R, Kotti S, Jung C, et al. TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohort. Am J Gastroenterol. 2009;104:384-391.
38. Yang SK, Lim J, Chang HS, et al. Association of TNFSF15 with Crohn's disease in Koreans. Am J Gastroenterol. 2008;103:1437-1442.